Dr. Caroline Fichtner

Principal / Authorized Signatory

Along with her experience in VC, biophysicist Dr Caroline Fichtner also spent many years working at the Max Planck Institute for Bioinorganic Chemistry in Mülheim an der Ruhr. At HTGF, the authorized signatory is responsible for the financing and development of technology start-ups in the life sciences field.

Portfolio

Posts & mentions

Press
4. October 2023

Inovedis Announces Close of Series A Funding Round 

Raises $4 Million in New Equity Funding  ALBSTADT, Germany – October 4, 2023 – Inovedis GmbH, a medical technology start-up dedicated to offering innovative solutions that contribute both to optimized patient care as well as minimizing the complexity of surgical interventions, announced the successful close of a Series A funding round totaling $4 million. This funding was supported by participation from all of Inovedis’s initial seed round investors including High-Tech Gründer
 
Press
24. August 2023

High-tech for sustainable agriculture

Call for Applications – AgriTech Pitch Day 2023 in Hannover Bonn and Hannover, August 24, 2023 – The AgriTech Pitch Day 2023 on September 28 in Hannover will focus on the future of agriculture. The event is organized by High-Tech Gründerfonds (HTGF) and RootCamp, with RootCamp serving as host. Founders of agricultural technology companies (AgriTech) will have the exclusive opportunity there to present their innovative solutions and ideas to a select group of investors, corporat
 
DNTOX Team
Press
14. June 2023

DNTOX receives €1.4 million seed funding for non-animal testing of chemicals

The life science startup enables non-animal testing of chemicals for neurotoxicity.  DNTOX receives €1.4 million from High-Tech Gründerfonds (HTGF), private investors Barbara Korte-Sturm and Nikolaus Sturm, Bool Capital, and AQAL Capital. The new capital will be used to set up the test laboratories in Düsseldorf, aim for GLP accreditation and launch the test battery on the market. Düsseldorf, June 14, 2023 – The Life Science startup DNTOX receives seed funding
 
HBOX Founding team
Press
22. February 2023

MedTech startup HBOX Therapies receives €2.3m in seed funding for protective lung support

The medtech start-up develops innovative treatment method for patients with lung failure. HBOX Therapies receives €2.3 million in seed funding from TechVision Fonds (TVF), High-Tech Gründerfonds (HTGF) and business angel Prof. Dr. Peter Borges. The fresh capital will be used to develop and test a first prototype, marking an important step towards clinical trials. Aachen, 22 February 2023 – HBOX Therapies raises €2.3m in seed funding. The round is led by TVF, with pa
 
resolve logo
Press
28. October 2022

Resolve Biosciences Secures $71 Million Series B Financing to Accelerate Commercial Expansion to Meet Global Demand for Molecular Cartography™ Workflow

Funding led by Patient Square Capital follows successful launch of groundbreaking system that delivers highest-resolution view of subcellular, single-molecule, spatial biology MONHEIM AM RHEIN, Germany – October 24, 2022 – Resolve Biosciences, the pioneer in Molecular Cartography™ technology, today announced it has secured a $71 million Series B financing. The latest round of funding was led by Patient Square Capital and included participation from EDBI, PS C
 

Events

Event
6. June 2024

AgriTech Pitch Day 2024

Are you an AgriTech founder and want to present your high-tech solutions for sustainable agriculture to leading investors and corporate decision-makers? Take the opportunity to pitch your technology to an exclusive audience of investors, corporate VCs, and industry experts! Together with our fund investor, Maschinenringe, High-Tech Gründerfonds is organizing AgriTech Pitch Day on 6 June in Neuburg an der Donau. Apply by 12 May. Register here with your company details and submit your non-confide